20 July 2023
SHARE NOW
ATW
Cell Therapy
Collaborations, Mergers & Acquisitions
GMP
Raw Materials
Strategy
This Briefing from Advanced Therapies Week 2023, hosted by Sony Biotechnology, focusses on the journey of collaboration between Sony Biotechnology and Sangamo, and how the partnership has led to advancing cell therapy product development.
In this Briefing, Aditi Singh (Sony Biotechnology) is joined by Nadia Lounnas-Moure (Sangamo Therapeutics France) and Cedric Ait Mansour (Sony Biotechnology). The panel explains how next cell therapy processes should start with a cell isolation multi-parameters selection to ensure the purity, a key attribute for patient safety. The panel goes on to explore how the development of clinical/GMP grade equipment in close collaboration allows the achievement of perfected equipment in line with the needs of cell therapy.
This Presentation was presented at Advanced Therapies Week 2023, in partnership with Sony Biotechnology.
More like this
Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment
Taysha is discontinuing the development of TSHA-120 in GAN following the Type C meeting feedback from the FDA
21 September 2023
Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux
Oxford Biomedica in Exclusive Talks to Acquire ABL Europe from Institut Mérieux.
20 September 2023
The Cell & Gene Therapy Manufacturing Capacity Map
The only live, interactive manufacturing capacity compendium for the advanced therapies industry.
20 September 2023
